-   Training & Support

[Expand/Collapse all sections]Expand all

Acute lymphoblastic leukaemia restriction and item codes

Do not share these attachments externally. See Freedom of Information -
Information Publication Scheme.

[\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation
Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.png]PBS
ALL blinatumomab/inotuzumab restriction and item codes

[\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation
Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.png]PBS
ALL imatinib/dasatinib/ponatinib restriction and item codes

Contact details

Complex Drugs Programs team

Forms

Acute lymphoblastic leukaemia - blinatumomab initial (induction) PBS
authority application (PB210)

Acute lymphoblastic leukaemia - inotuzumab initial (induction) PBS
authority application (PB269)

Acute lymphoblastic leukaemia – first line – dasatinib initial PBS
authority application (PB271)

Acute lymphoblastic leukaemia – second line - dasatinib initial PBS
authority application (PB077)

Acute lymphoblastic leukaemia - ponatinib - initial PBS authority
application form (PB169)

Services Australia website

Acute lymphoblastic leukaemia

External websites

PBS schedule for acute lymphoblastic leukaemia

                                   

-   Services Australia ABN 90 794 605 008 
